State Key Laboratory of Liver Research Symposium 2018
Date: |
December 1, 2018 (Saturday) Cheung Kung Hai Lecture Theatre |
08:30 am |
Registration |
09:00 am |
Opening Address |
Research Presentation I | |
09:05 am |
Identification and characterization of a novel gene Faci that alleviates high-fat diet-induced metabolic syndrome in mice |
09:25 am |
The Reprogramming of cis-acting super-enhancers landscape and deregulation of trans-acting super-enhancer machinery in human hepatocellular carcinoma |
09:45 am |
Genome-wide CRISPR/Cas9 library screening identified PHGDH in serine synthesis pathway as a critical driver for tyrosine kinase inhibitor resistance in HCC |
10:05 am |
ELF4 Co-operates with HBV DNA Integration at the TERT Promoter to Enhance Hepatocarcinogenesis |
10:25 am |
Tea Break |
Keynote Lecture I | |
10:45 am |
Innovative genetic approaches for hepatic repopulation |
Research Presentation II | |
11:30 am |
New strategies and compounds for cccDNA targeting through identification and characterization of cellular regulators of HBV transcription |
11:55 am |
Expanded potential stem cells and their applications for the study of liver |
12:20 pm |
The FoxA transcription factors and postnatal demethylation in the liver |
12:50 pm |
Lunch |
Keynote Lecture II | |
02:00 pm |
Update on HBV treatment |
Research Presentation III | |
02:45 pm |
Novel circulating HBV markers |
03:10 pm |
Update on non-invasive assessment of liver fibrosis and cirrhosis |
03:40 pm |
Conquering the Achilles’ heel of liver transplantation |
Research Presentation IV | |
04:05 pm |
Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma - a proposed management algorithm |
04:25 pm |
Importance of hepatitis B core antigen (HBcAg) and outcome of its inhibition |
04:45 pm |
Closing Remarks |
